The Belgravia Centre Blog

LaserComb FDA Clearance Misconception

There seems to be a number of common misconceptions related to hair loss products, one of the most popular being the idea that the HairMax LaserComb has only been cleared by the FDA for safety, not effectiveness.

If you read the FDA clearance letter sent to HairMax (the manufacturers of the LaserComb) you will see that it clearly states ‘The LaserComb is indicated to promote hair growth in males with androgenetic alopecia who have Norwood Hamilton classification of IIa to V and Fitzpatrick skin types of I to IV.’ Here’s the FDA clearance letter.

HairMax carried out a placebo-controlled clinical study at a number of sites in the US in order to prove the effectiveness of their device. Hopefully this information will clear this matter up. Here’s some more information – LaserComb FDA Clearance.

This entry was posted on Monday, May 11th, 2009 at 2:04 pm and is filed under General Hair Loss. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Comments

Comments Policy